Trellus Health plc (TRLS) ORD GBP0.0006

Sell:0.60pBuy:0.70pNo change

Prices delayed by at least 15 minutes
Sell:0.60p
Buy:0.70p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:0.60p
Buy:0.70p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Trellus Health plc is a United Kingdom-based healthcare company, which is engaged in providing solutions and services for chronic condition management. The Company is focused on chronic costly GI conditions that have high mental health burden, such as inflammatory bowel disease (IBD) which includes the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The Company has one division being the providing resilience-driven care for chronic conditions in the inflammatory bowel disease state. The Company’s Trellus Elevate platform is a connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Trellus Elevate’s personalized health roadmaps include engaging lessons and skill-building techniques designed to empower individuals. The Company’s wholly owned subsidiary is Trellus Health Inc.

Key people

Marla C. Dubinsky
Chief Executive Officer, Executive Director
Kevin L. Murphy
Non-Executive Independent Chairman of the Board
Erik Lium
Non-Executive Director
Mike Salter
Non-Executive Director
Traci Entel
Senior Independent Non-Executive Director
Brian Thomas Griffin
Non-Executive Independent Director
Click to see more

Key facts

  • Shares in issue
    161.51m
  • EPIC
    TRLS
  • ISIN
    GB00BNNFM402
  • Location
    United Kingdom
  • Sector
    Technology
  • Industry
    Software & Programming
  • Market cap
    £1.05m
  • Employees
    18
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.